These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18506357)

  • 1. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and innovative interventions in the management of pemphigus.
    Frydman AS; Fairley JA
    G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapy of pemphigus vulgaris.
    Fellner MJ; Sapadin AN
    Mt Sinai J Med; 2001; 68(4-5):268-78. PubMed ID: 11514914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time to re-evaluate the treatment of pemphigus?
    Leventhal JS; Sanchez MR
    J Drugs Dermatol; 2012 Oct; 11(10):1200-6. PubMed ID: 23134985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for pemphigus foliaceus.
    Fernando SL; Broadfoot AJ
    G Ital Dermatol Venereol; 2009 Aug; 144(4):363-77. PubMed ID: 19755942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjuvant therapy of pemphigus. An update.
    Bystryn JC; Steinman NM
    Arch Dermatol; 1996 Feb; 132(2):203-12. PubMed ID: 8629830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous immunoglobulin (TVIG) therapy in pemphigus].
    Ishii N; Hashimoto T
    Nihon Rinsho; 2010 Nov; 68(11):2143-6. PubMed ID: 21061546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus: a treatment update.
    Dick SE; Werth VP
    Autoimmunity; 2006 Nov; 39(7):591-9. PubMed ID: 17101503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actual management of pemphigus.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies for heart failure: focus on anti-inflammatory strategies.
    Ramasubbu K; Oliveira G; Torre-Amione G
    Congest Heart Fail; 2006; 12(3):153-9; quiz 160-1. PubMed ID: 16760701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mediated therapies for heart failure.
    Blum A
    Isr Med Assoc J; 2009 May; 11(5):301-5. PubMed ID: 19637509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind trial of intravenous immunoglobulin for pemphigus.
    Amagai M; Ikeda S; Shimizu H; Iizuka H; Hanada K; Aiba S; Kaneko F; Izaki S; Tamaki K; Ikezawa Z; Takigawa M; Seishima M; Tanaka T; Miyachi Y; Katayama I; Horiguchi Y; Miyagawa S; Furukawa F; Iwatsuki K; Hide M; Tokura Y; Furue M; Hashimoto T; Ihn H; Fujiwara S; Nishikawa T; Ogawa H; Kitajima Y; Hashimoto K;
    J Am Acad Dermatol; 2009 Apr; 60(4):595-603. PubMed ID: 19293008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Update of Autoimmune Blistering Diseases.
    Kridin K; Ahn C; Huang WC; Ansari A; Sami N
    Dermatol Clin; 2019 Apr; 37(2):215-228. PubMed ID: 30850044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
    Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
    Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?
    Celis R; Torre-Martinez G; Torre-Amione G
    Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatment for epidermolysis bullosa acquisita.
    Engineer L; Ahmed AR
    J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
    Tavakolpour S
    Int Immunopharmacol; 2017 Dec; 53():133-142. PubMed ID: 29107213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.